Bioequivalence of levamlodipine besylate tablets in healthy Chinese subjects: a single-dose and two-period crossover randomized study

BACKGROUND: Levamlodipine, a calcium channel blocker, has been show act as a cardiovascular drug. To compare the pharmacokinetic parameters between levamlodipine (test formulation) at a single dose of 5 mg and amlodipine (reference formulation) at a single dose of 10 mg, the bioequivalence study was...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xin, Wang, Chenjing, Li, Ting, Liu, Yanping, Liu, Shuqin, Tao, Ye, Ma, Yaping, Gao, Xiaomeng, Cao, Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7678077/
https://www.ncbi.nlm.nih.gov/pubmed/33213527
http://dx.doi.org/10.1186/s40360-020-00459-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7678077/
https://www.ncbi.nlm.nih.gov/pubmed/33213527
http://dx.doi.org/10.1186/s40360-020-00459-6

Ejemplares similares